Business Segments · Depreciation
Cardiovascular — Depreciation
Boston Scientific Cardiovascular — Depreciation decreased by 15.2% to $89M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.1%, from $78M to $89M. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Depreciation shows an upward trend with a 8.0% CAGR.
Analysis
StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
Rolls up toD&A
How to read this metric
An increase may signal significant capital investment in new manufacturing facilities or equipment for the cardiovascular segment.
Detailed definition
This metric tracks the systematic allocation of the cost of tangible assets used specifically within the cardiovascular...
Peer comparison
Similar to 'Segment Depreciation and Amortization' reported by peers in capital-intensive manufacturing sectors.
Metric ID:
bsx_segment_cardiovascular_depreciationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $65.25M | $65.25M | $65.25M | $61.25M | $61.25M | $61.25M | $61.25M | $65.75M | $65.75M | $65.75M | $65.75M | $66M | $71M | $75M | $91M | $78M | $83M | $89M | $105M | $89M |
| QoQ Change | — | +0.0% | +0.0% | -6.1% | +0.0% | +0.0% | +0.0% | +7.3% | +0.0% | +0.0% | +0.0% | +0.4% | +7.6% | +5.6% | +21.3% | -14.3% | +6.4% | +7.2% | +18.0% | -15.2% |
| YoY Change | — | — | — | — | -6.1% | -6.1% | -6.1% | +7.3% | +7.3% | +7.3% | +7.3% | +0.4% | +8.0% | +14.1% | +38.4% | +18.2% | +16.9% | +18.7% | +15.4% | +14.1% |
Range$61.25M – $105M
CAGR+6.8%
Avg YoY Growth+9.7%
Median YoY Growth+7.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — depreciation?
- Boston Scientific (BSX) reported cardiovascular — depreciation of $89M in Q1 2026.
- How has Boston Scientific's cardiovascular — depreciation changed year-over-year?
- Boston Scientific's cardiovascular — depreciation increased by 14.1% year-over-year, from $78M to $89M.
- What is the long-term trend for Boston Scientific's cardiovascular — depreciation?
- Over 4 years (2021 to 2025), Boston Scientific's cardiovascular — depreciation has grown at a 8.0% compound annual growth rate (CAGR), from $261M to $355M.
- What does cardiovascular — depreciation mean?
- The portion of cardiovascular segment asset costs recognized as an expense during the period.